Spherix IncorporatedBethesda, MD, United States (NASDAQ (GM): SPEX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Spherix Financial Statements

Spherix Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Spherix Income Statement

  2008 2007 2006
Revenue ($ mil.) 1.0 0.2 24.8
Gross Profit ($ mil.) 0.6 0.1 4.0
Operating Income ($ mil.) (6.2) (9.3) --
Total Net Income ($ mil.) (4.1) (0.9) 3.5
Diluted EPS (Net Income) (0.29) (0.07) 0.26
More Spherix financial information

Spherix Quarterly Statements

  Quarter Ending Jun 09 Quarter Ending Jun 09 Quarter Ending Mar 09
Revenue ($ mil.) 0.3 0.3 0.4
Gross Profit ($ mil.) 0.2 0.2 0.2
Operating Income ($ mil.) -- -- --
Total Net Income ($ mil.) (1.6) (1.6) (2.1)
Diluted EPS (Net Income) (0.11) (0.11) (0.14)
More Spherix financial information

Spherix Stock Quote & Chart

11/06/09 15:58:50 EST • NASDAQ • 1.85 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Spherix Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 20.24 1.52 7.01
Price/Earnings Ratio (4.34) 18.69 25.51
Price/Book Ratio 3.90 2.57 6.74
Price/Cash Flow Ratio (4.45) 11.61 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Spherix Financial Ratios

Spherix Competitive Intelligence

Eli Lilly Novo Nordisk Sanofi-Aventis
Annual Sales ($ mil.) 20,378.0 8,627.7 40,057.0
Employees 40,500 26,600 98,213
Market Cap ($ mil.) 39,641.3 40,721.8 96,562.0

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy